GABRIELLI, Armando
 Distribuzione geografica
Continente #
NA - Nord America 18.452
EU - Europa 10.616
AS - Asia 7.115
SA - Sud America 2.009
Continente sconosciuto - Info sul continente non disponibili 451
AF - Africa 416
OC - Oceania 9
AN - Antartide 1
Totale 39.069
Nazione #
US - Stati Uniti d'America 17.865
RU - Federazione Russa 2.742
SG - Singapore 2.182
IT - Italia 1.659
VN - Vietnam 1.626
BR - Brasile 1.558
UA - Ucraina 1.378
CN - Cina 1.166
DE - Germania 964
SE - Svezia 920
IE - Irlanda 749
FR - Francia 574
HK - Hong Kong 521
TR - Turchia 517
DK - Danimarca 464
FI - Finlandia 426
GB - Regno Unito 341
KR - Corea 249
CA - Canada 236
BD - Bangladesh 165
IN - India 165
AR - Argentina 146
CI - Costa d'Avorio 130
MX - Messico 101
EC - Ecuador 96
PL - Polonia 94
MA - Marocco 91
NL - Olanda 82
IQ - Iraq 78
ZA - Sudafrica 69
ID - Indonesia 68
JP - Giappone 58
CO - Colombia 54
VE - Venezuela 54
ES - Italia 44
PK - Pakistan 44
GT - Guatemala 39
IL - Israele 39
BE - Belgio 38
CR - Costa Rica 37
AT - Austria 32
SV - El Salvador 29
PY - Paraguay 28
CL - Cile 26
TN - Tunisia 26
UZ - Uzbekistan 26
TT - Trinidad e Tobago 25
PH - Filippine 24
NI - Nicaragua 23
SA - Arabia Saudita 23
HN - Honduras 22
PR - Porto Rico 20
EG - Egitto 19
SC - Seychelles 19
UY - Uruguay 18
KE - Kenya 17
LT - Lituania 17
MY - Malesia 17
GP - Guadalupe 16
RS - Serbia 16
CW - ???statistics.table.value.countryCode.CW??? 15
JM - Giamaica 15
NP - Nepal 15
EU - Europa 14
JO - Giordania 14
BO - Bolivia 13
AL - Albania 12
LB - Libano 12
OM - Oman 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
ET - Etiopia 11
PE - Perù 11
TH - Thailandia 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
TW - Taiwan 9
AM - Armenia 7
AU - Australia 7
AZ - Azerbaigian 7
IR - Iran 7
PS - Palestinian Territory 7
CH - Svizzera 6
HR - Croazia 6
RO - Romania 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
CZ - Repubblica Ceca 5
MD - Moldavia 5
PT - Portogallo 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
CG - Congo 4
GE - Georgia 4
GR - Grecia 4
PA - Panama 4
BB - Barbados 3
BY - Bielorussia 3
EE - Estonia 3
GA - Gabon 3
Totale 38.591
Città #
Ashburn 2.855
Chandler 1.449
Jacksonville 1.412
Singapore 1.330
Fairfield 836
Dublin 743
Council Bluffs 737
San Jose 728
Dallas 690
Boardman 685
Ho Chi Minh City 557
Wilmington 553
Hong Kong 503
New York 490
Woodbridge 393
Houston 373
Hanoi 362
Seattle 350
Beijing 343
Centro 323
The Dalles 314
Des Moines 311
Princeton 307
Lawrence 295
San Mateo 295
Los Angeles 273
Lauterbourg 270
Munich 258
Moscow 237
Cambridge 232
Ann Arbor 224
São Paulo 166
Hefei 160
Milan 159
Helsinki 150
Abidjan 129
San Diego 111
Buffalo 107
Chicago 89
Da Nang 86
Santa Clara 82
Orem 81
Haiphong 73
Turin 73
London 71
Phoenix 65
Rome 65
Warsaw 64
Montreal 57
Ancona 54
Rio de Janeiro 51
Atlanta 50
Brooklyn 49
Denver 48
Turku 48
Pune 46
Toronto 45
Chennai 43
Frankfurt am Main 43
Guangzhou 43
Tokyo 43
Washington 41
Johannesburg 40
Miano 39
Stockholm 38
Boston 37
Nuremberg 37
Shanghai 37
Brussels 35
Guatemala City 35
Marche 35
Redmond 35
Belo Horizonte 34
Porto Alegre 32
Quito 32
Mexico City 31
Brasília 30
Naples 30
Norwalk 29
Baghdad 28
Curitiba 28
Harper Woods 28
Guayaquil 27
Hải Dương 26
Poplar 26
Amsterdam 25
Manchester 25
San Francisco 25
San Salvador 24
Biên Hòa 23
San José 23
Tashkent 23
Wuhan 23
Jesi 22
Managua 21
Charlotte 20
Porto 20
Ankara 19
Jiaxing 19
Thái Bình 19
Totale 22.200
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 855
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 822
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 313
Diagnosis and management of leukocytoclastic vasculitis 229
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 224
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 201
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 197
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 189
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 188
Metabolomic profile of systemic sclerosis patients 186
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 186
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 185
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 182
Adalimumab modulates angiogenesis in psoriatic skin 181
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 181
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 180
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 179
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 178
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 178
Abnormal cerebrovascular reactivity and cognitive impairment in systemic sclerosis 176
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 176
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 175
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 174
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 173
c-MYB transactivates the alpha 2(I) collagen gene. 172
La terapia con immunoglobuline endovena nelle malattie autoimmuni 169
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 169
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 168
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 167
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 166
Cardiac involvement in polymyositis and dermatomyositis 165
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 164
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 162
Cognitive and cerebral hemodynamic impairment in scleroderma patients 161
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 161
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 161
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 160
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 160
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 159
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 159
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 159
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 158
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 158
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 158
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 158
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 157
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 157
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 157
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 156
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 155
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 155
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 155
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry 155
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 153
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 153
Subcutaneous IgG in the Myositis Spectrum Disorders 153
Subclinical progression of systemic sclerosis-related cardiomyopathy 151
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 151
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 150
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database 150
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 150
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 149
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 149
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 149
Certolizumab pegol for the treatment of psoriasis 149
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 148
Mapping and predicting mortality from systemic sclerosis 148
Assessment of gastrointestinal involvement in scleroderma. 147
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 146
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 145
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 145
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 144
A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA). 144
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 143
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 143
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 143
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 142
Digital ulcers predict a worse disease course in patients with systemic sclerosis 142
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 142
A painful diagnosis 142
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 141
Traiano: Educational (but not only) opportunity for Master Students 141
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 141
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 141
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 140
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 140
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 140
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 139
Agonistic antibodies in systemic sclerosis 139
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 138
Update of EULAR recommendations for the treatment of systemic sclerosis 138
Biologics in inflammatory immune-mediated systemic diseases 138
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 137
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 137
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 136
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 136
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 135
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 135
Dr. Guerra, et al reply 135
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 135
Totale 17.302
Categoria #
all - tutte 174.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.261 0 0 0 0 17 106 77 159 126 129 201 446
2022/20234.169 380 433 343 353 306 688 13 279 1.009 38 218 109
2023/20242.235 419 47 135 345 350 487 37 56 13 68 21 257
2024/20254.554 425 425 197 43 205 118 481 163 1.051 329 477 640
2025/202613.841 914 1.088 721 1.498 1.299 887 2.039 1.285 2.257 897 334 622
2026/20273.505 501 488 693 1.558 265 0 0 0 0 0 0 0
Totale 39.069